from AIR LIQUIDE (EPA:AI)
Voting rights
REGULATED INFORMATION
Paris, January 2, 2026
www.airliquide.com
Follow us Twitter @airliquidegroup
VOTING RIGHTS
FREE TRANSLATION OF DECLARATION TO AMF
ON NUMBER OF SHARES & VOTING RIGHTS
Declaration on December 31, 2025
| month | Total number of shares | Total number of voting rights (including treasury shares) | Total number of voting rights (excluding treasury shares) |
|---|---|---|---|
| December | 579,384,423 | 579,384,423 | 577,941,183 |
| Previous declaration November 2025 | |||
| November | 578,534,625 | 578,534,625 | 577,097,785 |
CONTACTS
Media Relations
media@airliquide.com
Investor Relations
IRTeam@airliquide.com
Shareholder Services
actionnaires@airliquide.com
Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 60 countries with approximately 66,500 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition - particularly with hydrogen - and takes action to progress in areas of healthcare, electronics and high technologies.
Air Liquide’s revenue amounted to more than 27 billion euros in 2024. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.